Bringing The World Home To You

© 2025 WUNC North Carolina Public Radio
120 Friday Center Dr
Chapel Hill, NC 27517
919.445.9150 | 800.962.9862

Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

Already a Sustainer? Click here to increase now →

White House strikes new deals to lower prices on obesity drugs for some

By Sydney Lupkin

Published November 7, 2025 at 4:56 AM EST

The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin

Stories From This Author

White House strikes deals for lower prices on obesity drugs

Sydney Lupkin

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole

Sydney Lupkin

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
AstraZeneca makes deal with White House to lower drug prices

Sydney Lupkin

The U.K.-based drugmaker became the second to strike a deal with the Trump administration as part of the president's push to rein in U.S. drug prices.